Esperion Therapeutics, Inc. Made Headway
Tue, Nov 23, 2021 at 05:30 PM
Esperion Therapeutics, Inc. (ESPR:NASDAQ) jumped higher at $10.02, representing a gain of 40.7%. On Mon, Nov 22, 2021, ESPR:NASDAQ touched a New 2-Week Low of $7.12. The stock got featured on our News Catalysts scanner on Fri, Nov 12, 2021 at 07:42 AM in the 'MISCELLANEOUS' category. From Mon, Nov 08, 2021, the stock recorded 0.00% Up Days and 0.00% Green Days
The stock spiked on Wed, Nov 03, 2021 at $10.83 with a volume of 1M+.
About Esperion Therapeutics, Inc. (ESPR:NASDAQ)
Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.
Top 10 Gainers:
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 162.81%
- KTTA (KTTA:NASDAQ), 153.39%
- QLGN (QLGN:NASDAQ), 104.8%
- VLON (VLON:NASDAQ), 81.59%
- PTPI (PTPI:NASDAQ), 75.94%
- ISPC (ISPC:NASDAQ), 48.54%
- MediciNova, Inc. (MNOV:NASDAQ), 43.97%
- VOSO (VOSO:NASDAQ), 43.95%
- CRXT (CRXT:NASDAQ), 42.96%
- Esperion Therapeutics, Inc. (ESPR:NASDAQ), 40.73%